Respiratory Institute, Cleveland Clinic, Cleveland, OH.
Division of Environmental and Occupational Health Sciences, National Jewish Health, Denver, CO.
Chest. 2020 Dec;158(6):2458-2466. doi: 10.1016/j.chest.2020.07.074. Epub 2020 Aug 6.
Beryllium exposure remains an ongoing occupational health concern for workers worldwide. Since the initial Occupational Safety and Health Administration (OSHA) ruling on a permissible exposure limit (PEL) for beryllium in 1971, our understanding of the risks of beryllium sensitization and chronic beryllium disease (CBD) has evolved substantially. A new OSHA ruling released in early 2017 and implemented in late 2018 reduced the PEL for beryllium, increased requirements for medical screening and monitoring, and may ultimately enhance worker protection. This review highlights advances in our understanding of the pathway from beryllium exposure to sensitization and progression to CBD that guided the development of this OSHA ruling. Screening workers exposed to beryllium and management of CBD will also be discussed. Finally, we will discuss the role of beryllium as a cause of morbidity and mortality among exposed workers in this potentially preventable occupational lung disease.
铍暴露仍然是全球工人的一个持续的职业健康关注点。自 1971 年职业安全与健康管理局(OSHA)首次对铍的容许接触限值(PEL)做出规定以来,我们对铍致敏和慢性铍病(CBD)风险的认识已经有了很大的发展。2017 年初发布并于 2018 年底实施的新 OSHA 规定降低了铍的 PEL,增加了医疗筛查和监测的要求,并最终增强了工人的保护。这篇综述强调了我们对从铍暴露到致敏和进展为 CBD 的途径的理解的进展,这些进展为这一 OSHA 规定的制定提供了指导。我们还将讨论对接触铍的工人进行筛查和管理 CBD。最后,我们将讨论铍作为这种潜在可预防的职业性肺病中暴露工人发病率和死亡率的原因。